Quantitative Hepatitis B Core Antibody Level Is a New Predictor for Treatment Response In HBeAg-positive Chronic Hepatitis B Patients Receiving Peginterferon

A recent study revealed that quantitative hepatitis B core antibody (qAnti-HBc) level could serve as a novel marker for predicting treatment response. In the present study, we further investigated the predictive value of qAnti-HBc level in HBeAg-positive patients undergoing PEG-IFN therapy. A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Feng-Qin, Song, Liu-Wei, Yuan, Quan, Fang, Lin-Lin, Ge, Sheng-Xiang, Zhang, Jun, Sheng, Ji-Fang, Xie, Dong-Ying, Shang, Jia, Wu, Shu-Huan, Sun, Yong-Tao, Wei, Shao-Feng, Wang, Mao-Rong, Wan, Mo-Bin, Jia, Ji-Dong, Luo, Guang-Han, Tang, Hong, Li, Shu-Chen, Niu, Jun-Qi, Zhou, Wei-dong, Sun, Li, Xia, Ning-Shao, Wang, Gui-Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279186/
https://www.ncbi.nlm.nih.gov/pubmed/25553110
http://dx.doi.org/10.7150/thno.10636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279186/
https://www.ncbi.nlm.nih.gov/pubmed/25553110
http://dx.doi.org/10.7150/thno.10636

Ejemplares similares